Literature DB >> 7380332

Liver disease and the e antigen in HBsAg carriers with chronic renal failure.

G P Coughlin, A G Van Deth, A P Disney, J Hay, A G Wangel.   

Abstract

This study was undertaken to assess the frequency of development and the stages of evolution of chronic liver disease in patients with renal failure who are chronic carriers of hepatitis B surface antigen. Cirrhosis or chronic active hepatitis developed in five of 21 patients and could not be predicted by the initial histological appearance or by HLA-A and B typing but was associated with the e antigen in four of the five patients. However, the antigen was not a consistent indicator of a poor prognosis, as the four other e antigen positive patients did not develop chronic liver disease during the period of the study. Transmission of hepatitis B to spouses occurred in four cases, was fatal in one instance, and was associated with e antigen in three of the four. Determination of e antigen status in renal unit patients who are carriers of hepatitis B surface antigen may be of value to the patient and his home environment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380332      PMCID: PMC1419355          DOI: 10.1136/gut.21.2.118

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.

Authors:  W A Briggs; J M Lazarus; A G Birtch; C L Hampers; E B Hager; J P Merrill
Journal:  Arch Intern Med       Date:  1973-07

2.  Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.

Authors:  T Shikata; T Uzawa; N Yoshiwara; T Akatsuka; S Yamazaki
Journal:  Jpn J Exp Med       Date:  1974-02

3.  Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.

Authors:  J O Nielsen; O Dietrichson; E Juhl
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

4.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

5.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

6.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

7.  An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

Authors:  W T London; M Di Figlia; A Sutnick; B S Blumberg
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

8.  [HL-A in liver diseases (author's transl)].

Authors:  J Freudenberg; K Erdmann; E Förster; J Berger
Journal:  Klin Wochenschr       Date:  1973-11

9.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

10.  Hepatitis B antigen, auto-antibodies and liver disease in a haemodialysis and transplantation unit.

Authors:  E C Campion; A G Wangel; J R Lawrence
Journal:  Aust N Z J Med       Date:  1975-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.